Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · Real-Time Price · USD
36.70
+3.47 (10.44%)
At close: Apr 24, 2025, 4:00 PM
36.17
-0.53 (-1.44%)
Pre-market: Apr 25, 2025, 5:01 AM EDT

Summit Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
27,07313,1601,829897263387
Upgrade
Market Cap Growth
619.43%619.43%103.94%241.23%-32.01%-28.06%
Upgrade
Enterprise Value
26,66812,7051,737779184366
Upgrade
Last Close Price
36.7017.842.614.252.694.70
Upgrade
PS Ratio
---1272.24145.30449.56
Upgrade
PB Ratio
69.6433.8523.547.083.164.87
Upgrade
P/TBV Ratio
69.9834.0224.137.183.715.87
Upgrade
EV/Sales Ratio
---1105.42101.96425.47
Upgrade
Debt / Equity Ratio
0.020.021.374.100.030.01
Upgrade
Asset Turnover
---0.000.020.01
Upgrade
Quick Ratio
9.909.909.179.153.473.85
Upgrade
Current Ratio
10.1510.159.3016.933.804.41
Upgrade
Return on Equity (ROE)
-94.89%-94.89%-601.85%-75.05%-108.89%-66.57%
Upgrade
Return on Assets (ROA)
-41.30%-41.30%-12.79%-10.23%-49.91%-32.91%
Upgrade
Return on Capital (ROIC)
-45.49%-45.49%-13.38%-10.87%-64.91%-40.97%
Upgrade
Earnings Yield
-0.82%-1.68%-33.62%-8.78%-33.71%-13.63%
Upgrade
FCF Yield
-0.53%-1.08%-4.20%-4.71%-27.73%-12.55%
Upgrade
Buyback Yield / Dilution
-15.96%-15.96%-220.50%-109.60%-32.67%-111.78%
Upgrade
Updated Feb 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q